Azithromycin for Injection Blend from Germany
Lyophilized bulk blend of azithromycin with lyoprotectants for reconstitution into anti-infective IV solutions treating pneumonia. Classified in 3003.90.01.80 for its mixed constituents, therapeutic anti-infective intent, and lack of retail/measured dosing. Used in large-scale hospital supply chains.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit DMF and validation data for lyophilization process compliance
• Ensure packaging prevents interpretation as 'put up for retail sale'
• Declare as 'other' anti-infectives only if not matching specific subheadings